Millions of people worldwide are battling Parkinson’s Disease (PD), a condition where brain cells slowly break down.
This process leads to a host of difficulties, both physical and mental, such as trouble moving smoothly and thinking clearly, and sometimes even dementia. Parkinson’s is second only to Alzheimer’s in its frequency among diseases that cause the brain to deteriorate due to aging.
For a long time, scientists have been trying to figure out exactly what causes PD, which has made finding effective treatments tough.
But a team of researchers from the University of Copenhagen has made an exciting breakthrough. They’ve found a problem in a key pathway that keeps the mitochondria, which are like tiny power stations in our cells, working well.
This issue prevents cells from getting rid of damaged mitochondria. As a result, cells run out of energy, and harmful proteins start to pile up, eventually leading to the death of brain cells.
An interesting part of this discovery is that immune genes, which usually protect us from viruses, are also vital for keeping the energy levels in nerve cells balanced.
When something goes wrong with these genes, it can make the mitochondria less efficient at producing energy, playing a role in the development of Parkinson’s Disease.
The researchers also found a connection between these pathways and how our bodies fight off infections, like COVID-19.
It turns out that a mutation in a gene related to these pathways can make the effects of COVID-19 much worse, linking the health of our nerve cells to our immune response against viruses.
Led by Professor Shohreh Issazadeh-Navikas, the research team looked at gene expression in the brains of people with PD and compared it to those without the disease. They discovered that the buildup of damaged mitochondria leads to more toxic proteins in the brain.
A protein called PIAS2 was more prevalent in those with Parkinson’s, suggesting it could be a marker for the disease. This is a big deal because it doesn’t just help us understand Parkinson’s better; it also opens up new possibilities for treatment.
Targeting this pathway could potentially stop PD from progressing and prevent the dementia that often comes with it.
The team believes that looking into how this pathway works in other types of Parkinson’s might lead to even more ways to fight this challenging condition.
This study, published in Molecular Psychiatry, brings new hope to those affected by Parkinson’s Disease.
Understanding how the regulation of mitochondria influences the health of neurons moves us closer to treatments that could lessen symptoms or even stop the disease before it starts.
As more research builds on these findings, the future looks brighter for people facing Parkinson’s.
This pioneering study not only improves our understanding of PD but also shows how connected our body’s systems are, from producing energy to fighting off infections, highlighting the delicate balance that keeps us alive.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more information about brain health, please see recent studies that blueberry supplements may prevent cognitive decline, and results showing Plant-based diets could protect cognitive health from air pollution.
Copyright © 2024 Knowridge Science Report. All rights reserved.
